New merger between Pfizer and Anacor to leverage opportunities in atopic dermatitis space:…
The severe atopic dermatitis market is set to be a difficult one for new entrants to penetrate
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Pharma M&As: value creator or value destroyer?
Anil Khanna, Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and…
Meningococcal vaccines market set to approach $1.8 bn by 2025: GlobalData
The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important…
Kandla SEZ: A cauldron of opportunities
Kandla SEZ, with its world class facilities, strategic location and technically advanced as well as customer focused support…
Regulated Product Submission: The upcoming data exchange standards
Divya Jaiswal, Business Analyst, HIL Domain Consulting Group, Infosys, Chandigarh, elaborates on how by implementing RPS, FDA will…
FDC BAN: HASTE MAKES WASTE?
Reacting strongly against the ban on 344 FDC drugs, industry veterans call it a hasty decision and question the government's…
Assessment of pharmacy registrations and renewals
Mansi Shah, Clinical Pharmacist, elaborates on registration renewals of pharmacists and opines that they should be based on…
Online CMEs: An emerging need
Phanish Chandra, CEO and Co-founder, Docplexus Online Services gives an insight on how time and cost constraints have led to the…
India’s medical devices market will hit $17.6 bn by 2020: GlobalData
The market will undergo significant changes, driven by mounting patient awareness of advancements in medical technology, and an…
CubeX maps health and wellness opportunity among Indian women
Its report also captures all the trends and new launches in the Indian women health market
The age of prodices
Susan Josi, Managing Partner, Sorento Healthcare, gives an insight on why healthcare companies must build new models of innovation…
Social media for doctors, the most awaited impetus for Indian healthcare
Phanish Chandra, CEO and Co-founder, Docplexus Online Services in this insight article gives an overview of about the relevance of…
Glioblastoma treatment market will expand five-fold to $3.3 billion by 2024: GlobalData
Japan will see the most impressive relative growth, with sales expanding from $47 million in 2014 to $268 million in 2024
Access to medicines: India’s strides since independence
Leena Menghaney, Regional Head, MSF Access Campaign, South Asia, in this article, explores milestones in policies that have had an…
Biosimilar trends in 2016
Spurring the growth of biosimilars is the need to improve access to biologics and contain treatment costs and healthcare budgets,…
Haemophilia A and B treatment market value will reach $6.3 billion by 2024: GlobalData
The increase represents a tepid CAGR of 1.52 per cent across Argentina and the seven major markets of the US, France, Italy,…
Jan Aushadhi Hindered By Hurdles
The Government was supposed to launch a policy for the ‘Jan Aushadhi Scheme’ in September 15. However, it has been delayed due to…
Multiple sclerosis treatment market value to reach $20 bn by 2024
The growth will primarily be driven by the continued uptake of premium products and an increase in treatment rates as a result of…
New blockbuster drugs will push multiple myeloma treatment market to $22.4 bn by 2023
The increase will be boosted by increasing therapeutic options, including the introduction of two monoclonal antibodies with…
HIV therapeutics market will crawl to $15.3 bn by 2023
The treatment landscape is expected to experience a paradigm shift towards integrase inhibitor drugs and single-tablet regimens